2 Interestingly, the ICSD-3 defines patients with excessive daytime sleepiness and lower CSF hypocretin-1 levels as having type 1 narcolepsy, even without cataplexy. In fact, measuring CSF levels of hypocretin-1 has been considered the best option for the diagnosis of type 1 narcolepsy 1 . However, the normal levels of hypocretin-1 are higher than 200 pg/mL 2 . Indeed, there is a grey zone between 110 pg/mL and 200 pg/mL that is not discussed in the literature.
We describe three patients with hypocretin-1 levels between 110 pg/mL and 200 pg/mL (Table) . All had the presence of allele HLA-DQB1*0602, sleep hallucinations, and sleep paralysis. Two patients had all the criteria for narcolepsy type 1, but one of them did not have all the criteria for narcolepsy.
The hypocretin-1 threshold of 110 pg/mL has been identified by two studies 2 . Quality Receiver Operating Characteristic curve analysis indicates a threshold of 200 pg/mL and 150 mg/mL for direct and extracted assays in volunteers, respectively 3, 4 . Although the biomarkers for identification of type 1 narcolepsy are very useful, the identification of patients with narcolepsy type 2 is still a challenge in many cases.
A paper written by Barateau et al. entitled Comorbidity between central disorders of hypersomnolence and immune-based disorders, expands this discussion.
5 They state that the prevalence of immune diseases, inflammatory disorders, and allergies are not higher in narcolepsy type 1. Interestingly, autoimmune diseases were higher in narcolepsy type 2 patients and inflammatory disorders were common in idiopathic hypersomnolence.
Clinical and neurophysiology characteristics, genetics and hypocretin-1 levels are not sufficient to define narcolepsy in all circumstances. Unfortunately, the description of a few patients cannot characterize a pattern, especially in atypical cases. Further efforts to study patients with hypocretin-1 between 110 pg/mL and 200 pg/mL should help to classify them. It is possible that, in the future, biomarkers of inflammation and immune responses will be useful for that. 
